Advance Your Knowledge: An Oral Treatment for Severe Alopecia Areata
Tuesday, January 28, 2025 at 2-3pm ET Pricing: Free for Members and Non-Members
Please note that this session is not accredited for continuing pharmacy education credit.
Program Description
The presentation will discuss LITFULO, ritlecitinib, indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older.
Learning Objectives
- Understand alopecia areata, with a brief overview of the disease state.
- Consider appropriate patients for oral treatment.
- Review LITFULO's efficacy and safety profile.
- Discuss initiation and monitoring of LITFULO.
This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.
Sponsored by:
For individuals from the media/press interested in attending, please email media@amcp.org.
Speaker:
Chikoti Wheat, MD, FAAD
Immediate Past President, Maryland Dermatologic Society
Anne Arundel Dermatology
Price
Required Hardware/software
AMCP Learn utilizes the Zoom Webinars platform for live webinars. For a smoother experience joining the webinar, please install the Zoom desktop client or mobile app prior to the start time. If you experience technical issues joining the webinar, please email webinars@amcp.org.